/PRNewswire/ ReiThera, a biotech company dedicated to the development of new technologies, GMP production and the clinical translation of genetic vaccines.
- New 1,500 sq.m. facility granted operational authorisation from AIFA, the Italian Medicines Agency, to enable production scales of up to 3,000 liters; - New facility will allow ReiThera
/PRNewswire/ ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and.
/PRNewswire/ ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and.
Program funded by the Bill & Melinda Gates Foundation will use ReiThera's GRAd platform technology to develop next generation vaccines against SARS-CoV-2 emerging variants and HIV ROME